Given that the diagnostics of MM is deficient in proper bio/tumor markers, the present work aimed to conduct a comprehensive clinical study focusing on the alterations recognized in the glycosylation pattern of AGP in melanoma. This evidence concerns the gene ATP5MK and melanoma.